BANAMINE®-S
(flunixin meglumine injection)
Product Description
Reduces fever in pigs with respiratory disease. Review complete label for directions and indications.
Indications
Indicated for the control of pyrexia associated with swine respiratory disease.
Downloads
Advantages
Reduces fever in pigs with respiratory disease.
- Quickly absorbed for a rapid fever reduction1
- The original flunixin meglumine anti-inflammatory is FDA-approved for reducing fevers associated with swine respiratory disease
- A potent non-steroidal anti-inflammatory drug (NSAID), having both analgesic and anti-fever properties
Important Safety Information
Do not use in animals showing hypersensitivity to flunixin meglumine. Use judiciously when renal impairment or gastric ulceration is suspected. Swine must not be slaughtered for human consumption within 12 days of the last treatment. Not for use in breeding swine. Intramuscular injection may cause local tissue irritation and damage. For complete information, see accompanying product package insert.
References
- Data on file, Merck Animal Health.
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global